Feb. 11, 2016—One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered.
Jun. 22, 2015—New Vanderbilt-led research shows hospitals are doing a better job of using antibiotics less commonly associated with antibiotic resistance to treat children hospitalized with community-acquired pneumonia (CAP).
Nov. 21, 2014—A family of single-celled organisms that thrive in environments too extreme for most other species to survive may be an untapped source of new antibacterial drugs.
Oct. 16, 2014—Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies.
Apr. 24, 2014—Vanderbilt University’s Richard Armstrong, Ph.D., is part of a multi-institutional research team that has found a new way to interrogate a “super family” of enzymes involved in detoxification, cellular metabolism and antibiotic resistance, which have many other as-yet-undiscovered functions.